NORTHERN TRUST CORP - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,092,539
+38.1%
1,206,763
+1.4%
0.00%0.0%
Q2 2023$3,688,468
+157.2%
1,189,828
+15.3%
0.00%
Q1 2023$1,434,320
-29.8%
1,031,885
+0.5%
0.00%
Q4 2022$2,043,963
-3.0%
1,027,117
-1.5%
0.00%
Q3 2022$2,107,000
-36.9%
1,042,549
-0.7%
0.00%
-100.0%
Q2 2022$3,341,000
-21.9%
1,050,388
+2.4%
0.00%0.0%
Q1 2022$4,277,000
-18.5%
1,025,795
-6.4%
0.00%0.0%
Q4 2021$5,250,000
-14.3%
1,095,867
-4.5%
0.00%0.0%
Q3 2021$6,126,000
-0.0%
1,147,242
-4.2%
0.00%0.0%
Q2 2021$6,128,000
-28.6%
1,196,980
-6.1%
0.00%
-50.0%
Q1 2021$8,583,000
+34.5%
1,275,306
-8.7%
0.00%
+100.0%
Q4 2020$6,381,000
+13.4%
1,396,461
-3.7%
0.00%0.0%
Q3 2020$5,625,000
-22.3%
1,449,809
-4.7%
0.00%
-50.0%
Q2 2020$7,241,000
+33.9%
1,521,360
-2.1%
0.00%0.0%
Q1 2020$5,409,000
-27.1%
1,554,407
+1.0%
0.00%0.0%
Q4 2019$7,415,000
+89.0%
1,538,324
+13.7%
0.00%
+100.0%
Q3 2019$3,923,000
-54.4%
1,352,584
+12.6%
0.00%
-50.0%
Q2 2019$8,609,000
-48.8%
1,200,738
+1.3%
0.00%
-50.0%
Q1 2019$16,802,000
+3.8%
1,185,777
-0.9%
0.00%
-20.0%
Q4 2018$16,192,000
-40.0%
1,196,715
-1.6%
0.01%
-28.6%
Q3 2018$27,000,000
+40.4%
1,216,749
+3.8%
0.01%
+40.0%
Q2 2018$19,237,0001,172,2920.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders